SFRP5 and bacterial infectious disease with sepsis: Hence, results point towards the activation of wnt signalling pathway in COVID-19, that might be even more pronounced in severe inflammation resulting from SARS-CoV-2 rather than classical bacterial septic infection due to the additional reduction of anti-inflammatory sFRP5 in COVID-19 but not in bacterial sepsis.